Skip to main content

EQT — Portfolio, Page 2

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

300
Companies
$7.7B
Total invested
$150.7M
Avg. check
55
Industries
Health Care 10Biotechnology 8Artificial Intelligence (AI) 6Information Technology 5Pharmaceutical 4Therapeutics 3+49 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 25–48 of 300
Candela
March 2026

Candela is an electric boats manufacturing company that builds electric hydrofoil boats, ferries for recreational and commercial purposes.

Boating · Stockholm$34.5M Series Unknown
Qevlar AI
March 2026

Qevlar AI is a SOC platform that enhances security operations by investigating alerts and correlating data to detect real threats.

Artificial Intelligence (AI) · Paris$30.0M Series A
Egle Therapeutics
March 2026

Egle Therapeutics is a biotechnology company focused on developing immunotherapies for oncology and autoimmune diseases.

Biotechnology · Paris$9.4M Grant
Tenpoint Therapeutics
January 2026

Tenpoint Therapeutics is a biotechnology company pursuing vision-restoring engineered cell-based therapeutics.

Biotechnology · Camborne$150.0M Debt Financing
SeeQC
January 2026

SeeQC is a semiconductor company that develops quantum computing systems and offers chip fabrication services to businesses.

Electronics · Elmsford$19.2M Venture - Series Unknown
Exciva
January 2026

Exciva develops clinical-stage biopharmaceutical therapies focused on addressing neuropsychiatric symptoms associated with dementia.

Biotechnology · Heidelberg$59.4M Series B
Kinaset Therapeutics
January 2026

Kinaset Therapeutics is a biopharma company that focuses on advancement of novel drugs in areas of unmet medical needs.

Health Care · Boston$103.0M Series B
ViCentra
January 2026

ViCentra has developed an insulin pump for diabetes patients.

Health Care · Utrecht$13.0M Series D
FoRx Therapeutics
December 2025

FoRx Therapeutics is a biotechnology company developing a new generation of cancer drugs focusing on novel DNA Replication Stress pathways.

Biotechnology · Basel$50.0M Series A
Kasada
December 2025

Kasada protects online, mobile, and API channels from system takeover, content scraping, DOS, and account takeover.

Computer · Sydney$19.9M Venture - Series Unknown
Artios Pharma
November 2025

Artios Pharma is a biopharmaceutical company that provides new solutions in the DNA damage response (DDR) field.

Biopharma · Cambridge$115.0M Series D
myTomorrows
November 2025

myTomorrows is a global platform that connects patients with unmet medical needs to treatments in development around the world.

Clinical Trials · Amsterdam$29.0M Private Equity
Dott
October 2025

Dott is a transportation company that offers shared electrical scooters and bikes.

Electric Vehicle · Amsterdam$81.6M Debt Financing
Endgame
October 2025

Endgame is transforming enterprise sales by turning every seller into a trusted advisor.

Artificial Intelligence (AI) · San Francisco$460K Venture - Series Unknown
Milvus Advanced
October 2025

Milvus Advanced is a chemical company that develops cutting-edge nanoalloys as substitutes for high-value metals crucial to decarbonisation.

Clean Energy · Oxford$6.9M Seed
Tubulis
October 2025

Tubulis generates antibody-drug conjugates with unique properties for solid tumor indications.

Biotechnology · Munich$400.6M Series C
Strawberry
October 2025

Strawberry is an agentic browser with built-in, personalized AI companions.

Artificial Intelligence (AI) · San Francisco$6.0M Seed
Supernova.io
September 2025

Supernova connects your design and engineering data in a single design system tool to accelerate and scale your product development.

Developer Tools · Prague$9.2M Series A
Filament
September 2025

Filament is operator of a communication platform intended to accelerate and amplify global change.

Information Technology · New York$10.7M Seed
Paid
September 2025

Paid is a business engine for AI agents.

Artificial Intelligence (AI) · London$21.6M Seed
Cyted
August 2025

Cyted uses artificial intelligence (AI) and digital pathology to improve the detection and diagnosis of diseases, including cancer.

Artificial Intelligence (AI) · Cambridge$44.0M Series B
Varjo
August 2025

Varjo makes advanced VR/XR hardware and software for industrial use, paving the way for a true-to-life metaverse.

Augmented Reality · Helsinki$5.9M Debt Financing
SNIPR Biome
August 2025

SNIPR Biome is a operator of a discovery stage biotech company intended to revolutionize the treatment of microbial diseases.

Biometrics · Copenhagen$40.8M Series B
Unmind
July 2025

Unmind is a B2B mental health platform providing clinically-backed tools and training.

Apps · London$35.0M Series C

Where EQT invests

Health Care10
Biotechnology8
Artificial Intelligence (AI)6
Information Technology5
Pharmaceutical4
Therapeutics3

About EQT's portfolio

How many companies has EQT invested in?▸

EQT has invested in 300 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does EQT invest in?▸

EQT's top investment sectors include Health Care, Biotechnology, Artificial Intelligence (AI), Information Technology, Pharmaceutical. The firm invests across 55 different industry categories.

What is EQT's largest investment?▸

Among tracked funding rounds, Tubulis received $400.6M in a Series C round. EQT's total known invested capital is $7.7B.

What is the average investment size for EQT?▸

EQT's average investment size is $150.7M across its portfolio of 300 companies.

What are EQT's most recent investments?▸

Recent EQT portfolio additions include Candela, Qevlar AI, Egle Therapeutics, Tenpoint Therapeutics, SeeQC. These companies were founded in 2020 or later.

Reach the founders behind these 300 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →